EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Half-Life of Long Forms of Cardiac Troponin T

Rasmus Bo Hasselbalch iD, Selma Salonen, Jonas Henrik Kristensen, Tuulia Tuominen, Nina Strandkjær iD, Morten Østergaard, Hasse Møller-Sørensen iD, Jens Christian Nilsson, Morten Dahl iD, Mustafa Vakur Bor, Ruth Frikke-Schmidt iD, Niklas Rye Jørgensen und 11 weitere

The Journal of Applied Laboratory Medicine · 17.09.2026

DOI: 10.1093/jalm/jfag142 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Applied Laboratory Medicine, online erschienen am 17.09.2026. Verfasst von Rasmus Bo Hasselbalch und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Copenhagen University Hospital-Herlev-Gentofte Hospital, Copenhagen, Denmark. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Candy's Foundation, Research Council of Herlev and Gentofte Hospital, Mauritzen la Fountaine Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Long forms of cardiac troponin T (cTnT) are promising markers that may differentiate myocardial infarction from other causes of acute and chronic myocardial injury. However, to understand the clinical utility of long cTnT, knowledge of the half-life (T½) is key. By using auto-transfusion in humans we determined the T½ of long forms of cTnT and compared long cTnT to a commercial high-sensitivity total cTnT assay.

Methods

Patients with ST-segment-elevation-myocardial infarction were included within 24 h after revascularization and underwent plasmapheresis to obtain plasma with a high cTnT concentration. After at least 3 weeks, patients returned for an autologous plasma re-transfusion followed by repeated blood sampling. A novel assay measured long cTnT and a commercially available assay measured total cTnT.

Results

We included 17 patients with median age 63 years (25th–75th percentiles 59–70), and 4 (24%) were female. The median concentrations after transfusion were 99 ng/L (54–125) for long cTnT vs 252 ng/L (233–322) for total cTnT. The median ratio of long cTnT to total cTnT was 0.39 (0.26–0.55) after transfusion and declined to 0.30 (0.20–0.44) after 60 min. Long cTnT displayed a 2-phase exponential decay, similar to what was observed for total cTnT but with shorter T½ both for the distribution phase [16 min (11–18) vs 22 min (20–24), P < 0.001] and the elimination phase [103 min (78–125) vs 133 min (114–168), P < 0.001].

Conclusion

The elimination of long forms of cTnT was faster than for total cTnT following re-transfusion. This understanding could aid in differentiating myocardial infarction from other causes of acute and chronic myocardial injury.

Autor:innen und Institutionen

  • Department of Cardiology, Copenhagen University Hospital-Herlev-Gentofte Hospital, Copenhagen, Denmark.
  • Department of Emergency Medicine, Copenhagen University Hospital-Herlev-Gentofte Hospital, Copenhagen, Denmark.
  • Department of Cardiology, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
  • Biotechnology Unit, Department of Life Technologies, University of Turku, Turku, Finland.
  • Department of Cardiothoracic Anaesthesiology, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
  • Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

ORCID-Profile: Rasmus Bo Hasselbalch, Nina Strandkjær, Hasse Møller-Sørensen, Morten Dahl, Ruth Frikke-Schmidt, Lene Holmvang, Jesper Kjærgaard, Allan S Jaffe, Saara Wittfooth

Förderung

  • Candy's Foundation
  • Research Council of Herlev and Gentofte Hospital
  • Mauritzen la Fountaine Foundation
  • the Finnish Foundation for Cardiovascular Research
  • the Turku University Foundation
  • the Varsinais-Suomi Regional Fund
  • Finnish Cultural Foundation
  • Candy’s Foundation

Zitieren

APA

Hasselbalch, R. B., Salonen, S., Kristensen, J. H., Tuominen, T., Strandkjær, N., Østergaard, M., Møller-Sørensen, H., Nilsson, J. C., Dahl, M., Bor, M. V., Frikke-Schmidt, R., Jørgensen, N. R., Rode, L., Holmvang, L., Kjærgaard, J., Bang, L. E., Forman, J., Dalhoff, K. P., Jaffe, A. S., …, & Iversen, K. K. (2026). The Half-Life of Long Forms of Cardiac Troponin T. The Journal of Applied Laboratory Medicine. https://doi.org/10.1093/jalm/jfag142

Vancouver

Hasselbalch RB, Salonen S, Kristensen JH, Tuominen T, Strandkjær N, Østergaard M, et al. The Half-Life of Long Forms of Cardiac Troponin T. The Journal of Applied Laboratory Medicine. 2026. doi:10.1093/jalm/jfag142

BibTeX
@article{Hasselbalch2026,
  author = {Hasselbalch, Rasmus Bo and Salonen, Selma and Kristensen, Jonas Henrik and Tuominen, Tuulia and Strandkjær, Nina and Østergaard, Morten and Møller-Sørensen, Hasse and Nilsson, Jens Christian and Dahl, Morten and Bor, Mustafa Vakur and Frikke-Schmidt, Ruth and Jørgensen, Niklas Rye and Rode, Line and Holmvang, Lene and Kjærgaard, Jesper and Bang, Lia E and Forman, Julie and Dalhoff, Kim P and Jaffe, Allan S and Thygesen, Kristian and Bundgaard, Henning and Wittfooth, Saara and Iversen, Kasper Karmark},
  title = {The Half-Life of Long Forms of Cardiac Troponin T},
  journal = {The Journal of Applied Laboratory Medicine},
  year = {2026},
  doi = {10.1093/jalm/jfag142}
}
Kostenlos starten →